Tumor Targeting Strategies of Smart Fluorescent Nanoparticles and Their Applications in Cancer Diagnosis and Treatment

Jiuyang He,Chenchen Li,Lin Ding,Yanan Huang,Xuelian Yin,Junfeng Zhang,Jian Zhang,Chenjie Yao,Minmin Liang,Rogério P. Pirraco,Jie Chen,Quan Lu,Ryan Baldridge,Yong Zhang,Minghong Wu,Rui L. Reis,Yanli Wang

DOI: https://doi.org/10.1002/adma.201902409

IF: 29.4

2019-08-01

Advanced Materials

Abstract:<p>Advantages such as strong signal strength, resistance to photobleaching, tunable fluorescence emissions, high sensitivity, and biocompatibility are the driving forces for the application of fluorescent nanoparticles (FNPs) in cancer diagnosis and therapy. In addition, the large surface area and easy modification of FNPs provide a platform for the design of multifunctional nanoparticles (MFNPs) for tumor targeting, diagnosis, and treatment. In order to obtain better targeting and therapeutic effects, it is necessary to understand the properties and targeting mechanisms of FNPs, which are the foundation and play a key role in the targeting design of nanoparticles (NPs). Widely accepted and applied targeting mechanisms such as enhanced permeability and retention (EPR) effect, active targeting, and tumor microenvironment (TME) targeting are summarized here. Additionally, a freshly discovered targeting mechanism is introduced, termed cell membrane permeability targeting (CMPT), which improves the tumor‐targeting rate from less than 5% of the EPR effect to more than 50%. A new design strategy is also summarized, which is promising for future clinical targeting NPs/nanomedicines design. The targeting mechanism and design strategy will inspire new insights and thoughts on targeting design and will speed up precision medicine and contribute to cancer therapy and early diagnosis.</p>

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are to improve the efficiency of tumor - targeted therapy and reduce side effects. Specifically, the paper explores the application of Smart Fluorescent Nanoparticles (SFNs) in cancer diagnosis and treatment, especially improving the accuracy of drug delivery through different tumor - targeted strategies. Due to poor selectivity, traditional chemotherapy drugs not only kill tumor cells but also damage normal cells and tissues, resulting in severe toxicity and side effects. Fluorescent nanoparticles show great potential in cancer diagnosis and treatment because of their high signal intensity, resistance to photobleaching, tunable fluorescence emission, high sensitivity and biocompatibility. The paper also discusses how to design more effective Multifunctional Nanoparticles (MFNPs) by understanding the properties and targeting mechanisms of fluorescent nanoparticles to achieve better tumor - targeting effects.

It is mentioned in the article that widely accepted and applied targeting mechanisms include the Enhanced Permeability and Retention effect (EPR), active targeting, Tumor Microenvironment (TME) targeting, etc. In addition, a newly discovered targeting mechanism - Cell Membrane Permeability Targeting (CMPT) is also introduced. This mechanism can increase the tumor - targeting rate from less than 5% of the EPR effect to more than 50%. This new design strategy is expected to accelerate the design of clinical targeted nano - drugs, promote the development of precision medicine, and contribute to cancer treatment and early diagnosis.